Floatz logo

Vrp-Encapsulated Sarna Encoding Il-12

SCC - Squamous Cell Carcinoma

VLP Therapeuticsgene_therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

28 Active assets in the SCC - Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
Neonc Technologies, Inc.
Phase 4BB
CIS-DIAMMINEDICHLOROPLATINUM II
University of Oxford
Phase 3BB
Docetaxel
Hummingbird Bioscience
Phase 2BB
Fibrin Sealant
Oxford University Hospitals NHS Trust
Phase 4BB
Eloxatin
University of Oxford
Phase 3BB

View all 50 →

Same molecule, other indications

Vrp-Encapsulated Sarna Encoding Il-12 is also rated in:

head and neck squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
Head Neck CancerDormant
CC
Indicative ·
43 / 100
View asset →
mouth disorderDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →